These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34815418)

  • 41. Behavioral deficits in an Angelman syndrome model: effects of genetic background and age.
    Huang HS; Burns AJ; Nonneman RJ; Baker LK; Riddick NV; Nikolova VD; Riday TT; Yashiro K; Philpot BD; Moy SS
    Behav Brain Res; 2013 Apr; 243():79-90. PubMed ID: 23295389
    [TBL] [Abstract][Full Text] [Related]  

  • 42. UBE3A regulates the transcription of IRF, an antiviral immunity.
    Furumai R; Tamada K; Liu X; Takumi T
    Hum Mol Genet; 2019 Jun; 28(12):1947-1958. PubMed ID: 30690483
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization and structure-activity relationships of indenoisoquinoline-derived topoisomerase I inhibitors in unsilencing the dormant
    Lee HM; Clark EP; Kuijer MB; Cushman M; Pommier Y; Philpot BD
    Mol Autism; 2018; 9():45. PubMed ID: 30140420
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Angelman syndrome protein Ube3a/E6AP is required for Golgi acidification and surface protein sialylation.
    Condon KH; Ho J; Robinson CG; Hanus C; Ehlers MD
    J Neurosci; 2013 Feb; 33(9):3799-814. PubMed ID: 23447592
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neurodevelopmental profile of siblings with Angelman syndrome due to pathogenic UBE3A variants.
    Sadhwani A; Willen JM; Miller H; Barbieri-Welge R; Horowitz LT; Noll LM; Peters S; Hundley R; Bird LM; Tan WH
    J Intellect Disabil Res; 2020 Mar; 64(3):246-250. PubMed ID: 31854050
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Angelman syndrome protein UBE3A interacts with primary microcephaly protein ASPM, localizes to centrosomes and regulates chromosome segregation.
    Singhmar P; Kumar A
    PLoS One; 2011; 6(5):e20397. PubMed ID: 21633703
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Towards a therapy for Angelman syndrome by targeting a long non-coding RNA.
    Meng L; Ward AJ; Chun S; Bennett CF; Beaudet AL; Rigo F
    Nature; 2015 Feb; 518(7539):409-12. PubMed ID: 25470045
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CRISPR/Cas9 directed to the Ube3a antisense transcript improves Angelman syndrome phenotype in mice.
    Schmid RS; Deng X; Panikker P; Msackyi M; Breton C; Wilson JM
    J Clin Invest; 2021 Mar; 131(5):. PubMed ID: 33411694
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Angelman syndrome-derived neurons display late onset of paternal UBE3A silencing.
    Stanurova J; Neureiter A; Hiber M; de Oliveira Kessler H; Stolp K; Goetzke R; Klein D; Bankfalvi A; Klump H; Steenpass L
    Sci Rep; 2016 Aug; 6():30792. PubMed ID: 27484051
    [TBL] [Abstract][Full Text] [Related]  

  • 50.
    Wallace ML; van Woerden GM; Elgersma Y; Smith SL; Philpot BD
    J Neurophysiol; 2017 Jul; 118(1):634-646. PubMed ID: 28468997
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The spectrum of mutations in UBE3A causing Angelman syndrome.
    Fang P; Lev-Lehman E; Tsai TF; Matsuura T; Benton CS; Sutcliffe JS; Christian SL; Kubota T; Halley DJ; Meijers-Heijboer H; Langlois S; Graham JM; Beuten J; Willems PJ; Ledbetter DH; Beaudet AL
    Hum Mol Genet; 1999 Jan; 8(1):129-35. PubMed ID: 9887341
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitative proteomics reveals neuronal ubiquitination of Rngo/Ddi1 and several proteasomal subunits by Ube3a, accounting for the complexity of Angelman syndrome.
    Ramirez J; Lectez B; Osinalde N; Sivá M; Elu N; Aloria K; Procházková M; Perez C; Martínez-Hernández J; Barrio R; Šašková KG; Arizmendi JM; Mayor U
    Hum Mol Genet; 2018 Jun; 27(11):1955-1971. PubMed ID: 29788202
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Decreased Axon Caliber Underlies Loss of Fiber Tract Integrity, Disproportional Reductions in White Matter Volume, and Microcephaly in Angelman Syndrome Model Mice.
    Judson MC; Burette AC; Thaxton CL; Pribisko AL; Shen MD; Rumple AM; Del Cid WA; Paniagua B; Styner M; Weinberg RJ; Philpot BD
    J Neurosci; 2017 Aug; 37(31):7347-7361. PubMed ID: 28663201
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Maternal Loss of Ube3a Impairs Experience-Driven Dendritic Spine Maintenance in the Developing Visual Cortex.
    Kim H; Kunz PA; Mooney R; Philpot BD; Smith SL
    J Neurosci; 2016 Apr; 36(17):4888-94. PubMed ID: 27122043
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recovery of Angelman syndrome rat deficits with UBE3A protein supplementation.
    Dodge A; Morrill NK; Weeber EJ; Nash KR
    Mol Cell Neurosci; 2022 May; 120():103724. PubMed ID: 35367589
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Generation of an induced pluripotent stem cell line from a patient with Angelman syndrome carrying UBE3A mutation.
    Li S; Zhu Q; Cai Y; Yang Q
    Stem Cell Res; 2022 Jul; 62():102791. PubMed ID: 35489268
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Abnormal electrophysiological phenotypes and sleep deficits in a mouse model of Angelman Syndrome.
    Copping NA; Silverman JL
    Mol Autism; 2021 Feb; 12(1):9. PubMed ID: 33549123
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cross-species considerations in models of neurodevelopmental disorders.
    Till SM; Hickson RDL; Kind PC
    Trends Neurosci; 2022 Mar; 45(3):171-172. PubMed ID: 34998618
    [TBL] [Abstract][Full Text] [Related]  

  • 59. JNK signaling activation in the Ube3a maternal deficient mouse model: its specific inhibition prevents post-synaptic protein-enriched fraction alterations and cognitive deficits in Angelman Syndrome model.
    Musi CA; Agrò G; Buccarello L; Camuso S; Borsello T
    Neurobiol Dis; 2020 Jul; 140():104812. PubMed ID: 32087286
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Angelman syndrome-associated ubiquitin ligase UBE3A/E6AP mutants interfere with the proteolytic activity of the proteasome.
    Tomaić V; Banks L
    Cell Death Dis; 2015 Jan; 6(1):e1625. PubMed ID: 25633294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.